Overview
- 2 inspections across 2 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-02-22.
At a glance
Inspections
2
Sites
2
Observations
0
Career since
Feb 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 22 Feb 2019 | Human Drugs | |
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) | 22 Feb 2019 | Human Drugs |
Sites inspected
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.Nanjing, China1 insp.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Christopher T Middendorf2 shared
Full investigator report
Get the verbatim findings behind Jane L Chang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site